MercoPress, en Español
Montevideo, March 9th 2025 - 14:34 UTC
A Chinese court on Friday fined British drug-maker GlaxoSmithKline 3.0 billion Yuan (490 million dollars) following a nearly year-long bribery probe, the company said.
Get our news on your inbox! Suscribe